These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
400 related items for PubMed ID: 30782173
1. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription. Xu L, Zhang X, Cheng W, Wang Y, Yi K, Wang Z, Zhang Y, Shao L, Zhao T. Retrovirology; 2019 Feb 19; 16(1):5. PubMed ID: 30782173 [Abstract] [Full Text] [Related]
2. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis. Hu J, Song J, Tang Z, Wei S, Chen L, Zhou R. Eur J Pharmacol; 2021 Jun 05; 900():174071. PubMed ID: 33811836 [Abstract] [Full Text] [Related]
3. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. Barathan M, Mariappan V, Shankar EM, Abdullah BJ, Goh KL, Vadivelu J. Cell Death Dis; 2013 Jun 27; 4(6):e697. PubMed ID: 23807226 [Abstract] [Full Text] [Related]
4. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin. Seitz G, Krause R, Fuchs J, Heitmann H, Armeanu S, Ruck P, Warmann SW. Oncol Rep; 2008 Nov 27; 20(5):1277-82. PubMed ID: 18949433 [Abstract] [Full Text] [Related]
5. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin. Kleban J, Szilárdiová B, Mikes J, Horváth V, Sacková V, Brezáni P, Hofmanová J, Kozubík A, Fedorocko P. J Photochem Photobiol B; 2006 Aug 01; 84(2):79-88. PubMed ID: 16545574 [Abstract] [Full Text] [Related]
6. Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer. Khot MI, Perry SL, Maisey T, Armstrong G, Andrew H, Hughes TA, Kapur N, Jayne DG. Photodiagnosis Photodyn Ther; 2018 Sep 01; 23():221-229. PubMed ID: 29969677 [Abstract] [Full Text] [Related]
7. Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro. Ocker L, Adamus A, Hempfling L, Wagner B, Vahdad R, Verburg FA, Luster M, Schurrat T, Bier D, Frank M, Lisec J, Engel N, Seitz G. Photodiagnosis Photodyn Ther; 2020 Mar 01; 29():101588. PubMed ID: 31704507 [Abstract] [Full Text] [Related]
8. Photodynamic therapy with hypericin induces vascular damage and apoptosis in the RIF-1 mouse tumor model. Chen B, Roskams T, Xu Y, Agostinis P, de Witte PA. Int J Cancer; 2002 Mar 10; 98(2):284-90. PubMed ID: 11857421 [Abstract] [Full Text] [Related]
9. Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma. El Hajj H, Khalil B, Ghandour B, Nasr R, Shahine S, Ghantous A, Abdel-Samad R, Sinjab A, Hasegawa H, Jabbour M, Hall WW, Zaatari G, Dbaibo G, Pisano C, Bazarbachi A, Darwiche N. Blood; 2014 Sep 25; 124(13):2072-80. PubMed ID: 25035162 [Abstract] [Full Text] [Related]
11. YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy. Gyurászová K, Mikeš J, Halaburková A, Jendželovský R, Fedoročko P. Photochem Photobiol Sci; 2016 Jun 08; 15(6):812-21. PubMed ID: 27241169 [Abstract] [Full Text] [Related]
12. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells. Wang X, Guo Y, Yang S, Wang C, Fu X, Wang J, Mao Y, Zhang J, Li Y. J Pharmacol Exp Ther; 2010 Sep 01; 334(3):847-53. PubMed ID: 20551295 [Abstract] [Full Text] [Related]
13. Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells. Berlanda J, Kiesslich T, Oberdanner CB, Obermair FJ, Krammer B, Plaetzer K. J Environ Pathol Toxicol Oncol; 2006 Sep 01; 25(1-2):173-88. PubMed ID: 16566716 [Abstract] [Full Text] [Related]
14. Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Tomita M, Kawakami H, Uchihara JN, Okudaira T, Masuda M, Takasu N, Matsuda T, Ohta T, Tanaka Y, Ohshiro K, Mori N. Int J Cancer; 2006 Feb 01; 118(3):765-72. PubMed ID: 16106398 [Abstract] [Full Text] [Related]
15. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer. Kim H, Kim SW, Seok KH, Hwang CW, Ahn JC, Jin JO, Kang HW. Photodiagnosis Photodyn Ther; 2018 Dec 01; 24():15-21. PubMed ID: 30118906 [Abstract] [Full Text] [Related]
16. Synergism between PKCδ regulators hypericin and rottlerin enhances apoptosis in U87 MG glioma cells after light stimulation. Misuth M, Horvath D, Miskovsky P, Huntosova V. Photodiagnosis Photodyn Ther; 2017 Jun 01; 18():267-274. PubMed ID: 28373118 [Abstract] [Full Text] [Related]
17. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Lavie G, Kaplinsky C, Toren A, Aizman I, Meruelo D, Mazur Y, Mandel M. Br J Cancer; 1999 Feb 01; 79(3-4):423-32. PubMed ID: 10027308 [Abstract] [Full Text] [Related]
18. Phototoxicity in a laryngeal cancer cell line enhanced by a targeting amphiphilic chlorin photosensitizer. Moritz MNO, Rossa C, de Oliveira KT, Uliana MP, Perussi JR. Photodiagnosis Photodyn Ther; 2017 Sep 01; 19():355-362. PubMed ID: 28716739 [Abstract] [Full Text] [Related]
19. Conjunction of glutathione level, NAD(P)H/FAD redox status and hypericin content as a potential factor affecting colon cancer cell resistance to photodynamic therapy with hypericin. Mikešová L, Mikeš J, Kovaľ J, Gyurászová K, Culka L, Vargová J, Valeková B, Fedoročko P. Photodiagnosis Photodyn Ther; 2013 Dec 01; 10(4):470-83. PubMed ID: 24284100 [Abstract] [Full Text] [Related]
20. Arsenic trioxide and the growth of human T-cell leukemia virus type I infected T-cell lines. Ishitsuka K, Hanada S, Uozumi K, Utsunomiya A, Arima T. Leuk Lymphoma; 2000 May 01; 37(5-6):649-55. PubMed ID: 11042529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]